MF
RVNC

Magnetar Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History

Magnetar Financial’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,556,345
Closed -$7.77M – 1007
2024
Q4 		$7.77M Buy
2,556,345
+56,174
+2% +$245K 0.18% 101
2024
Q3 		$13M Buy
+2,500,171
New +$12.4M 0.28% 83

Other funds holding RVNC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Magnetar Financial's RVNC Position: Q1 2025 in Review

Magnetar Financial sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 2,556,345 shares — an estimated $7.77M sold.

Magnetar Financial first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $13M in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

  • Magnetar Financial reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
  • Magnetar Financial sold 2,556,345 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $7.77M.
  • Magnetar Financial first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
  • Magnetar Financial's Revance Therapeutics, Inc. position peaked at $13M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Magnetar Financial's 13F filing for Q1 2025, filed 15 May 2025.